Ledger.Open graph →
SEC Form D · Amendment · filed November 1, 2022

hC Bioscience, Inc

Offering
$40.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Other
Location
Cambridge, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Brad J. Margus · Cambridge, MADirectorSeiji J. Miyahara · Cambridge, MADirectorLeslie J. Williams · Boston, MAExec · DirectorBenjamin J. Chen · Cambridge, MADirectorSacha J. Mann · Boston, MADirectorDavid J. Moskowitz · Boston, MADirectorSteven J. Gillis · Boston, MADirectorBrad J. Margus · Cambridge, MADirectorLeslie J. Williams · Boston, MAExec · DirectorBenjamin J. Chen · Cambridge, MADirectorSeiji J. Miyahara · Cambridge, MADirectorSacha J. Mann · Boston, MADirectorDavid J. Moskowitz · Boston, MADirectorSteven J. Gillis · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗